t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE
168 Ratings
Rs 4,160 Rs 3,200
23 % OFF
CHROMOSOMAL REARRANGEMENTS CAN PRODUCE TUMORIGENIC FUSION GENES. THIS MECHANISM IS SEEN IN 15-25% OF LEUKEMIAS, LYMPHOMAS & SARCOMAS. FUSIONS CAN BE PRODUCED BY TRANSLOCATIONS, INVERSIONS OR DELETIONS. SPECIFIC GENE FUSIONS IN A PATIENTS TUMOR CELLS HAVE AN IMPORTANT BEARING ON THE MANAGEMENT & PROGNOSIS. MLL FUSION GENE IN MIXED LINEAGE LEUKEMIAS IS OBSERVED WITH EQUAL FREQUENCY IN AML & ALL. IT IS A POOR PROGNOSTIC MARKER IN ALL.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
3 ML (2 ML MIN.) WHOLE BLOOD / BONE MARROW IN 1 LAVENDER TOP (EDTA) TUBE. SHIP REFRIGERATED. DO NOT FREEZE. CLINICAL HISTORY IS MANDATORY.
REAL TIME PCR
REPORT ON 4TH DAY EVENING 7PM
CLINICAL HISTORY IS MANDATORY.
